Seventh Sense is developing an array of products based on the company's proprietary Touch Activated Phlebotomy (TAP) painless blood collection platform, with an initial focus on enabling important diagnostic testing at the point of care by reducing the discomfort, anxiety and hassle of blood sample collection.
Polaris allows small highly focused technology-centered companies like Seventh Sense to access resources that we absolutely need but are often reluctant to retain directly. Whether it’s public relations, executive search and independent director recruiting, business development expertise or just meeting other CEOs in adjacent industries, it’s a huge advantage to be able to tap into Polaris’ established and well regarded network of advisors and investors.
- Howard Weisman, CEO : Seventh Sense
286 Cardinal Medeiros Avenue, Cambridge, MA, 02141
Tel: 617-547-7246
www.7sbio.com